Active Startup: NexPlasmaGen

Published: 9 October 2019

Business Snapshot
The company manufactures a low temperature plasma device for biomedical applications. For cancer applications, the technology will kill cancer cells while avoiding the surrounding healthy tissue.

Target Markets
Oncology, specifically breast cancer.

Intellectual Property
Granted patents in the US and Canada

Valérie Léveillé

Back to top